Latest market price
430.36
-1.34-0.31%
OverviewShort InterestFilings
MDGLQT33Madrigal Pharmaceuticals, Inc.·NASDAQ
430.36-0.31%

Latest SEC Filings

Form category
DescriptionFilingDocument
Sep 11, 20264Statement of changes in beneficial ownership
Aug 20, 20264Statement of changes in beneficial ownership
Aug 18, 20264Statement of changes in beneficial ownership
Aug 18, 20263Initial statement of beneficial ownership
Aug 12, 20268-KCurrent report
Jul 30, 20268-KCurrent report
Jul 30, 202610-QQuarterly report
Jul 29, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 20, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 18, 20264Statement of changes in beneficial ownership
Jun 17, 2026S-8Registration of employee benefit securities
Jun 17, 20268-KCurrent report
Jun 01, 20264Statement of changes in beneficial ownership
May 22, 20264Statement of changes in beneficial ownership
May 18, 20264Statement of changes in beneficial ownership
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 06, 202610-QQuarterly report
May 06, 20268-KCurrent report
Apr 28, 2026DEF 14ADefinitive proxy statement
#1 / 25 of 341
Page
▼
/ 14